We investigated interactions between the hypoxia and TGF-β signaling pathways in vitro by examining bone-metastatic MDA-MB-231 breast cancer cells for changes in TGF-β and hypoxia-stimulated gene expression of 16 candidate genes. The gene discussed is TGFB1; the disease is breast carcinoma.